the effects of Scaphoid and Hamate mobilization in patients with carpal tunnel syndrome

Not Applicable

Conditions: Carpal Tunnel Syndrome.
Carpal Tunnel Syndrome

Registration Number: IRCT2015120125317N1

Lead Sponsor: Shahid Moderres Hospital of Tehran

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: Female

Target Recruitment: 40

Inclusion Criteria

Inclusion Criteria: patient with mild and moderate CTS confirmed by the presence of 1 or more of the following standard electrophysiological criteria:1- prolonged distal motor latency (DML) (abnormal =4.2 ms)of Median nerve and 2) prolonged antidromic distal sensory latency (DSL) to the third digit (abnormal >3.6 ms. Exclusion criteria:Pregnancy; Severe degree CTS; Background metabolic diseases such as: Diabetes mellitus; Hypothyroidism; Rheumatoid arthritis; Previous history of Corticosteroid injection in Carpal Tunnel; Severe atrophy of Thener muscles; cervical radiculopathy or significant polyneuropathy; Unwillingness to participate in the present study;

Exclusion Criteria

Not provided

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain. Timepoint: 0, 8 weeks after treatment. Method of measurement: Visual Analog Scale, that is from 0-10 and zero (0) means that you did not have any pain and ten (10) means that you had the worst pain imaginable.;Symptome Severity(pain and paresthesia). Timepoint: 0, 8 weeks after treatment. Method of measurement: Bostone/levine Symptome Severity Scale Questionnaire.;Functional Status. Timepoint: 0, 8 weeks after treatment. Method of measurement: Bostone/levine Functional Status Scale Questionnare.;Distal Sensory Peak Latency(SNAP) of median nerve. Timepoint: 0, 8 weeks after treatment. Method of measurement: EDX Indexes.;Distal Motor Onset Latency(CMAP) of median nerve. Timepoint: 0, 8 weeks after treatment. Method of measurement: EDX indexes.

Secondary Outcome Measures